Kitasato University: Clinical Trials

9 trials sponsored by Kitasato University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 4 unknown, 1 recruiting. 4 Phase 2, 2 Phase 1, 2 Phase 4, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Unknown 2
Phase 12Completed 2
Phase 42Completed 1, Unknown 1
Not applicable1Recruiting 1

Follow Kitasato University: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pulsed Field Ablation vs. Cryoballoon Ablation in Patients With Persistent Atrial Fibrillation
Catheter ablation using pulsed field ablation, Catheter ablation using cryoballoon ablation - Persistent Atrial Fibrillation
Not applicableRecruitingKitasato University3002025-06-252025-08-26
Study in COvid-19 Patients With iveRmectin (CORVETTE-01)
Ivermectin 3 MG, Placebo - Covid19
Phase 2UnknownKitasato University2142020-09-162022-01-20
Multiple Dose Escalation Study of M201-A in Healthy Japanese Subjects
M201-A Injection, Placebo - Healthy Volunteers
Phase 1CompletedKitasato University182020-03-302021-08-31
First-in-Patient Study for Sing le Dose of M201-A Hydrochloride Injection in Japanese Patients With Paroxysmal Atrial Fibrillation
M201-A Injection, Placebo - Paroxysmal Atrial Fibrillation
Phase 2UnknownKitasato University422019-05-072020-10-30
iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study
Bosutinib (Phase 1 part), Bosutinib (Phase 2 part) - Amyotrophic Lateral Sclerosis
Phase 1 / Phase 2CompletedKyoto University462019-03-192026-08-10
Kitasato PCI Registry
Intra-coronary imaging device, PCI procedural characteristics - Acute Coronary Syndrome, STEMI - ST-segment Elevation Myocardial Infarction
UnknownKitasato University45002012-02-012022-04-04
Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension
Intensive therapy Valsartan,Fluvastatin - Type 2 Diabetes Mellitus, Hypertension
Phase 4UnknownKitasato University802006-10-012007-10-23
Clinical Trial of Chemosensitivity Test
S-1 - Gastric Cancer
Phase 2CompletedJapan Clinical Cancer Research Organization3002006-03-012011-06-29
Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
valsartan, Conventional antihypertensive drugs - Chronic Kidney Disease, Hypertension
Phase 4CompletedKVT-Study Group3122003-02-012015-03-31

Conditions studied

Atrial Fibrillation (2)  ·  Hypertension (2)  ·  Acute Coronary Syndrome (1)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Angina, Stable (1)  ·  Atherosclerosis (1)  ·  COVID-19 (1)  ·  Cardiovascular Diseases (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Diabetic Nephropathies (1)  ·  Ischemia (1)  ·  Renal Insufficiency, Chronic (1)  ·  Stomach Neoplasms (1)

Interventions

Fluvastatin (1)  ·  Ivermectin (1)  ·  S 1 (combination) (1)  ·  Valsartan (1)  ·  bosutinib (1)

Countries

Japan (9)

Top investigators

Haruhisa Inoue (1)  ·  Keiji Tanaka, MD,PhD (1)  ·  Kenjiro Kimura, MD, PhD (1)  ·  Kunihiro K.Y Yamaoka, Ph.D (1)  ·  Tetsuro Kubota, Processor (1)  ·  Yoshiyasu Minami (1)

Results publications

PMID 26385385, PMID 36467452, PMID 37283627, PMID 39461864